NEW YORK, April 25, 2023 ‒ Aetion ®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce the culmination of the RCT-DUPLICATE demonstration project, with ...
The What Works Clearinghouse (WWC) identifies studies that provide credible and reliable evidence of a given intervention’s effectiveness. Yet there is a high potential for serious estimation bias ...
In this article, we provide an up-to-date review of the commonly used biomarker-based phase III RCT designs. In the next section, we examine the salient features of each design, with a particular ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
CHICAGO – Loxo Oncology Inc.'s announcement that it will seek tissue-agnostic approval for larotrectinib (LOXO-101) based on data that were presented at this year's ASCO meeting came just weeks after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results